Literature DB >> 11779201

Regulation of transformed state by calpastatin via PKCepsilon in NIH3T3 mouse fibroblasts.

Takaki Hiwasa1, Mitsuyuki Nakata, Miho Nakata, Shigeo Ohno, Masatoshi Maki, Koichi Suzuki, Masaki Takiguchi.   

Abstract

Ca(2+)-activated neutral protease calpain is ubiquitously expressed and may have pleiotropic biological functions. We have previously reported that repeated treatment of NIH3T3 mouse fibroblasts with the calpain inhibitor N-acetyl-Leu-Leu-norleucinal (ALLN) resulted in the induction of transformed foci [T. Hiwasa, T. Sawada, and S. Sakiyama (1990) Carcinogenesis 11, 75-80]. To elucidate further the effects of calpain in malignant transformation of NIH3T3 cells, calpastatin, an endogenous specific inhibitor of calpain, was expressed in NIH3T3 cells by transfection with cDNA. G418-selected calpastatin-expressing clones showed a significant increase in the anchorage-independent growth ability. A similar increase in cloning efficiency in soft agar medium was also observed in calpain small-subunit-transfected clones. On the other hand, reduced expression of calpastatin achieved by transfection with calpastatin antisense cDNA in Ha-ras-transformed NIH3T3 (ras-NIH) cells caused morphological reversion as well as a decrease in anchorage-independent growth. When NIH3T3 cells were treated with ALLN for 3 days, cell growth was stimulated by approximately 10%. This growth stimulation by ALLN was not observed in ras-NIH cells, but recovered by expression of a dominant negative form of protein kinase C (PKC)epsilon but not by that of PKCalpha. Western blotting analysis showed that an increase in PKCepsilon was much more prominent than that of PKCalpha in NIH3T3 cells after treatment with ALLN. These results are concordant with the notion that calpain suppresses malignant transformation by predominant degradation of PKCepsilon. (c)2002 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779201     DOI: 10.1006/bbrc.2001.6197

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Calpain activity is generally elevated during transformation but has oncogene-specific biological functions.

Authors:  N O Carragher; B D Fonseca; M C Frame
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

2.  MiR-34a regulates blood-tumor barrier function by targeting protein kinase Cε.

Authors:  Wei Zhao; Ping Wang; Jun Ma; Yun-Hui Liu; Zhen Li; Zhi-Qing Li; Zhen-Hua Wang; Liang-Yu Chen; Yi-Xue Xue
Journal:  Mol Biol Cell       Date:  2015-03-18       Impact factor: 4.138

3.  Analogues of Y27632 increase gap junction communication and suppress the formation of transformed NIH3T3 colonies.

Authors:  L Hampson; X T He; A W Oliver; J A Hadfield; T Kemp; J Butler; A McGown; H C Kitchener; I N Hampson
Journal:  Br J Cancer       Date:  2009-09-01       Impact factor: 7.640

4.  Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma.

Authors:  Hideaki Shimada; Tooru Shiratori; Mari Yasuraoka; Akiko Kagaya; Mari Kuboshima; Fumio Nomura; Masaki Takiguchi; Takenori Ochiai; Hisahiro Matsubara; Takaki Hiwasa
Journal:  BMC Cancer       Date:  2009-07-15       Impact factor: 4.430

5.  The growth and tumor suppressors NORE1A and RASSF1A are targets for calpain-mediated proteolysis.

Authors:  Sergey Kuznetsov; Andrei V Khokhlatchev
Journal:  PLoS One       Date:  2008-12-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.